s6y
Company name or ticker
Search
Evogene Ltd.
424B3
Prospectus filed pursuant to Rule 424(b)(3)
Filed
Thursday, March 31, 2022
Accession number
0001178913-22-001346
Documents
424B3
424B3
FILING FEES TABLE
EX-99
On sec.gov
Filing index
All files
Complete submission text
SGML header